First Trust Capital Management’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-19,335
Closed -$578K – 178
2025
Q3
$578K Hold
19,335
– – 0.04% 114
2025
Q2
$574K Sell
19,335
-586
-3% -$16.9K 0.04% 113
2025
Q1
$608K Buy
19,921
+3,516
+21% +$118K 0.04% 87
2024
Q4
$650K Sell
16,405
-1,172
-7% -$45.6K 0.05% 82
2024
Q3
$682K Buy
+17,577
New +$711K 0.05% 103

Other funds holding SRDX

First Trust Capital Management's SRDX Position: Q4 2025 in Review

First Trust Capital Management sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 19,335 shares — an estimated $578K sold.

First Trust Capital Management first reported a position in SRDX in Q3 2024 and held it in 5 quarters. The position peaked at $682K in Q3 2024. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

  • First Trust Capital Management reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
  • First Trust Capital Management sold 19,335 Surmodics shares in Q4 2025, an estimated $578K.
  • First Trust Capital Management first reported a position in Surmodics in Q3 2024 and held it in 5 quarters.
  • First Trust Capital Management's Surmodics position peaked at $682K in Q3 2024.
  • 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on First Trust Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.